Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04530786 · ClinicalTrials.gov registry record
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 100
- Enrollment target
NCT04530786: Completed study, sponsored by University of Wisconsin, Madison.
NCT04530786 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04530786 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate influenza vaccine-induced antibodies in lung transplant patients beyond the season of vaccination.
Primary Outcome
Influenza antibody concentrations against viruses no longer included in the vaccine were measured in serum by hemagglutination inhibition assay (HIA) annually following vaccination of lung transplant participants and healthy controls.
Interventions
- DRUG Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
What the finished NCT04530786 record still lists
NCT04530786 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.
NCT04530786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04530786 about?
NCT04530786 is a clinical study titled "Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season". This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate influenza vaccine-induced antibo...
What is the current status of trial NCT04530786?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2004-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT04530786?
The interventions under investigation include: Influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT04530786?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia